Registration Header
Greenbrook TMS Q2, 2020 Financial Results Conference Call and Webcast

Start Date:8/5/2020

Start Time:10:00 AM EDT

Duration:60 minutes


About Greenbrook TMS Inc.


Operating through 109 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 320,000 TMS treatments to over 9,000 patients struggling with depression.

If you're already registered for the Greenbrook TMS Q2, 2020 Financial Results Conference Call and Webcast webcast, click below:

ALREADY REGISTERED?
First Name
Last Name
Company
Email Address
Phone Number
©2019 West Corporation. All rights reserved.